A

Aro Biotherapeutics

48 employees

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Biotechnology
Licensing
Drug Delivery
Drug Discovery
Health Care
Tissue-specific Targeting
Protein Therapeutics
Therapeutics
siRNA
Immunology
Drug Development
Protein Engineering
Oligonucleotide Delivery
Targeted Nanoparticles
Genetic Medicine
Medical
Bispecifics
Protein Conjugation

Date founded

2018

Funding rounds raised

Total raised

$88M

from 6 investors over 6 rounds

A

Aro Biotherapeutics raised $88M on January 5, 2021

Investors: BioMotiv, Ionis Pharmaceuticals, Inc., Ridgeback Capital Management LLC, HealthCap and Northpond Ventures

A

Aro Biotherapeutics raised $13M on December 11, 2018

Investors: BioMotiv

FAQ